ClearPoint Neuro, Inc. reaffirms revenue guidance for the full year 2022. For the year, company reaffirmed its revenue outlook of between $21.0 million and $22.0 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.52 USD | +1.85% | +3.95% | -18.70% |
04-30 | Clinical Laserthermia Notes US FDA Clearance for ClearPoint's Prism Bone Anchor Accessory | MT |
04-29 | ClearPoint Gets FDA Clearance For Neurosurgical Equipment | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.70% | 149M | |
+7.62% | 218B | |
+6.70% | 183B | |
+11.94% | 134B | |
+24.60% | 106B | |
-1.71% | 61.12B | |
+4.81% | 50.89B | |
+11.55% | 51.26B | |
-1.09% | 40.3B | |
+26.82% | 32.05B |
- Stock Market
- Equities
- CLPT Stock
- News ClearPoint Neuro, Inc.
- ClearPoint Neuro, Inc. Reaffirms Revenue Guidance for the Full Year 2022